SkinBioTherapeutics Plc
SBTX.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £4,779 | £801 | £1,312 | £1,805 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £1,411 | £341 | £1 | £13 |
| Inventory | £800 | £472 | £33 | £123 |
| Other Curr. Assets | £117 | £57 | £375 | £392 |
| Total Curr. Assets | £7,108 | £1,671 | £1,721 | £2,333 |
| Property Plant & Equip (Net) | £728 | £116 | £173 | £127 |
| Goodwill | £2,420 | £2,038 | £0 | £0 |
| Intangibles | £1,869 | £1,389 | £700 | £626 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £5,017 | £3,544 | £873 | £752 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £12,126 | £5,215 | £2,594 | £3,085 |
| Liabilities | – | – | – | – |
| Payables | £513 | £281 | £194 | £73 |
| Short-Term Debt | £112 | £779 | £62 | -£5 |
| Tax Payable | £155 | £65 | £63 | £32 |
| Deferred Revenue | £0 | £0 | £0 | £32 |
| Other Curr. Liab. | £688 | £679 | £210 | £377 |
| Total Curr. Liab. | £1,469 | £1,805 | £530 | £509 |
| LT Debt | £881 | £40 | £70 | £101 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £356 | £151 | £0 | £0 |
| Other NC Liab. | £0 | £250 | £0 | £0 |
| Total NC Liab. | £1,237 | £440 | £70 | £101 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £393 | £79 | £101 | £128 |
| Total Liabilities | £2,707 | £2,245 | £599 | £610 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £2,588 | £2,023 | £1,731 | £1,568 |
| Retained Earnings | -£14,695 | -£13,999 | -£11,123 | -£8,288 |
| AOCI | £439 | £439 | £439 | £437 |
| Other Equity | £21,088 | £14,508 | £10,948 | £8,758 |
| Total Equity | £9,419 | £2,970 | £1,995 | £2,475 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £12,126 | £5,215 | £2,594 | £3,085 |
| Net Debt | -£3,786 | £18 | -£1,180 | -£1,709 |